Print this page    •   Back to Web version of article

NIAID to Host Public Meeting on Future HIV/AIDS Research Networks

September 16, 2010

Future Directions for National Institute of Allergy and Infectious Diseases Research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH will host a public meeting on Tuesday, October 26, 2010, in Arlington, Va., to examine the future of the Institute's HIV/AIDS clinical trial networks. Currently, NIAID supports six HIV/AIDS networks; the awards supporting those networks are set to expire in 2013 and 2014.

NIAID aims to broaden the scope of the networks to include research for other infectious diseases of significance to people with or at risk for HIV infection, including tuberculosis and hepatitis. The future of NIAID's HIV/AIDS clinical trial networks has been the topic of a continued series of blog posts here on

At the meeting, NIAID and its NIH collaborating partners will present key expectations for the future networks with a focus on potential changes in network structure, research priorities, collaborative opportunities and information about the upcoming application process. Ample time for questions and answers will be made available.

The meeting will be held from 8:00 a.m. to 5:30 p.m. EST at the Crystal Gateway Marriott, 1700 Jefferson Davis Highway, Arlington, Va. 22202. To register for the meeting, please visit: The registration form may also be used to submit questions in advance of the meeting.

Proceedings from the meeting will be videotaped and later posted to the NIAID Web site.

This article was provided by You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.